Best practice in therapeutic drug monitoring
- PMID: 9723816
- PMCID: PMC1873661
- DOI: 10.1046/j.1365-2125.1998.00770.x
Best practice in therapeutic drug monitoring
Abstract
It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.
Figures
Comment in
-
Target concentration intervention: beyond Y2K.Br J Clin Pharmacol. 1999 Jul;48(1):9-13. doi: 10.1046/j.1365-2125.1999.00971.x. Br J Clin Pharmacol. 1999. PMID: 10383553 Free PMC article.
Similar articles
-
Best practice in therapeutic drug monitoring.Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):5S-10S. doi: 10.1046/j.1365-2125.2001.0520s1005.x. Br J Clin Pharmacol. 2001. PMID: 11564048 Free PMC article. Review.
-
Therapeutic drug monitoring in a developing country: an overview.Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):103S-108S. doi: 10.1046/j.1365-2125.2001.0520s1103.x. Br J Clin Pharmacol. 2001. PMID: 11564058 Free PMC article. Review.
-
Delivery of therapeutic drug monitoring services: survey of Australasian clinical pharmacology laboratories.Ther Drug Monit. 1998 Dec;20(6):598-601. doi: 10.1097/00007691-199812000-00002. Ther Drug Monit. 1998. PMID: 9853972
-
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.Eur J Clin Pharmacol. 2008 Feb;64(2):159-66. doi: 10.1007/s00228-007-0430-1. Epub 2008 Jan 15. Eur J Clin Pharmacol. 2008. PMID: 18196227 Review.
-
Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.Ther Drug Monit. 2010 Oct;32(5):615-23. doi: 10.1097/FTD.0b013e3181ea3e8a. Ther Drug Monit. 2010. PMID: 20683393
Cited by
-
Two-dimensional temperature-responsive chromatography using a poly(N-isopropylacrylamide) brush-modified stationary phase for effective therapeutic drug monitoring.Sci Rep. 2022 Feb 16;12(1):2653. doi: 10.1038/s41598-022-06638-1. Sci Rep. 2022. PMID: 35173260 Free PMC article.
-
Therapeutic drug monitoring in a developing country: an overview.Br J Clin Pharmacol. 1999 Nov;48(5):649-54. doi: 10.1046/j.1365-2125.1999.00088.x. Br J Clin Pharmacol. 1999. PMID: 10594465 Free PMC article. Review.
-
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions.Drug Saf. 2001;24(13):947-59. doi: 10.2165/00002018-200124130-00002. Drug Saf. 2001. PMID: 11735651 Review.
-
Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice.J Pers Med. 2020 Jun 29;10(3):56. doi: 10.3390/jpm10030056. J Pers Med. 2020. PMID: 32610469 Free PMC article. Review.
-
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.Front Pharmacol. 2020 Mar 3;11:177. doi: 10.3389/fphar.2020.00177. eCollection 2020. Front Pharmacol. 2020. PMID: 32194413 Free PMC article. Review.
References
-
- Levy G, Ebling WF, Forrest A. Concentration- or effect-controlled clinical trials with sparse data. Clin Pharmacol Ther. 1994;56:1–8. - PubMed
-
- Campbell M. Community-based therapeutic drug monitoring. Clin Pharmacokinet. 1995;28:271–274. - PubMed
-
- Birkett DJ. Therapeutic drug monitoring. Australian Prescriber. 1997;20:9–11.
-
- Spector R, Park GD, Johnson G, et al. Therapeutic drug monitoring. Clin Pharmacol Ther. 1988;43:345–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources